Effect of surface-modified paclitaxel nanowires on U937 cells in vitro: A novel drug delivery vehicle

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have fabricated surface-modified paclitaxel nanowires (SM-PNs) with a precise diameter and an average length of 50m. The surface of these nanowires is coated with a monolayer of octadecylsiloxane (ODS), which prevents aggregation and enhances dispersivity in aqueous media. This system constitutes a novel drug delivery vehicle based on one-dimensional (1D) nanostructures with a large drug to vehicle ratio. We assayed the cytotoxicity of different diameter SM-PNs (200, 80, 35, and 18nm) with U937 cells and compared their activity to microcrystalline paclitaxel. SM-PNs reduced U937 cell proliferation in culture followed by cell death. For the same amount of paclitaxel, different diameter SM-PNs displayed different cytotoxic effect at the same incubation time period. SM-PNs with 35nm diameters were the most efficient in completely halting cell proliferation following the first 24 hours of treatment, associated with 42 cell death. SM-PNs with 18nm diameters were least effective. These SM-PNs can be tailored to fit a certain treatment protocol by simply choosing the appropriate diameter. Copyright © 2012 Mohamed H. Abumaree et al.

Cite

CITATION STYLE

APA

Abumaree, M. H., Al-Suwaidan, S., & Al-Kaysi, R. O. (2012). Effect of surface-modified paclitaxel nanowires on U937 cells in vitro: A novel drug delivery vehicle. Journal of Nanomaterials, 2012. https://doi.org/10.1155/2012/328520

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free